P. Łoś

416 total citations
18 papers, 346 citations indexed

About

P. Łoś is a scholar working on Cancer Research, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, P. Łoś has authored 18 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cancer Research, 11 papers in Hematology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in P. Łoś's work include Protease and Inhibitor Mechanisms (14 papers), Blood Coagulation and Thrombosis Mechanisms (10 papers) and Blood properties and coagulation (9 papers). P. Łoś is often cited by papers focused on Protease and Inhibitor Mechanisms (14 papers), Blood Coagulation and Thrombosis Mechanisms (10 papers) and Blood properties and coagulation (9 papers). P. Łoś collaborates with scholars based in Netherlands and Denmark. P. Łoś's co-authors include Cornelis Kluft, A.F.H. Jie, Daan J.A. Crommelin, C Kluft, E. de Wit, Louis M. Havekes, Inge Clemmensen, J.J. Emeis, Edo Vellenga and VW van Hinsbergh and has published in prestigious journals such as Blood, Journal of the American College of Cardiology and Biochemical and Biophysical Research Communications.

In The Last Decade

P. Łoś

18 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Łoś Netherlands 11 187 160 102 83 43 18 346
V. Fleury France 6 222 1.2× 160 1.0× 93 0.9× 108 1.3× 12 0.3× 7 366
I. Vanlinthout Belgium 10 154 0.8× 153 1.0× 97 1.0× 90 1.1× 8 0.2× 17 363
Melanie E. DeFord United States 7 173 0.9× 81 0.5× 197 1.9× 68 0.8× 7 0.2× 9 366
Luigi Tomao Italy 11 152 0.8× 36 0.2× 177 1.7× 74 0.9× 15 0.3× 22 398
George S. Tamvakopoulos United Kingdom 7 207 1.1× 45 0.3× 174 1.7× 49 0.6× 11 0.3× 11 441
Sirpa Osman Finland 6 204 1.1× 100 0.6× 117 1.1× 65 0.8× 10 0.2× 6 551
Franziska Leonhardt Germany 10 93 0.5× 105 0.7× 145 1.4× 24 0.3× 9 0.2× 13 385
Sonja Seidl Austria 11 76 0.4× 190 1.2× 430 4.2× 61 0.7× 7 0.2× 25 599
Keting Que China 7 131 0.7× 42 0.3× 206 2.0× 118 1.4× 13 0.3× 9 413
Yuye Shi China 12 57 0.3× 130 0.8× 129 1.3× 25 0.3× 11 0.3× 38 340

Countries citing papers authored by P. Łoś

Since Specialization
Citations

This map shows the geographic impact of P. Łoś's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Łoś with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Łoś more than expected).

Fields of papers citing papers by P. Łoś

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Łoś. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Łoś. The network helps show where P. Łoś may publish in the future.

Co-authorship network of co-authors of P. Łoś

This figure shows the co-authorship network connecting the top 25 collaborators of P. Łoś. A scholar is included among the top collaborators of P. Łoś based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Łoś. P. Łoś is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Nicpoń, J., et al.. (2011). Evaluation of selected antioxidant enzymes in the blood of horses with recurrent airways obstruction.. Medycyna Weterynaryjna. 67(2). 129–132. 3 indexed citations
2.
Łoś, P., et al.. (1998). The inactivation of single-chain urokinase-type plasminogen activator by thrombin in a plasma milieu. Blood Coagulation & Fibrinolysis. 9(5). 419–428. 11 indexed citations
3.
Leebeek, Frank W.G., P. Łoś, & Cornelis Kluft. (1996). A monoclonal antibody against the COOH-terminal site of α2-antiplasmin reveals heterogeneity in the non-plasminogen binding form of α2-antiplasmin. Fibrinolysis and Proteolysis. 10. 67–70. 2 indexed citations
4.
Łoś, P., et al.. (1996). Fibrin Binding of Plasminogen Coated Liposomes In Vitro. Thrombosis and Haemostasis. 75(1). 134–139. 4 indexed citations
5.
Łoś, P., et al.. (1995). Thrombolytic Treatment with Tissue-type Plasminogen Activator (t-PA) Containing Liposomes in Rabbits: a Comparison with Free t-PA. Thrombosis and Haemostasis. 73(3). 488–494. 72 indexed citations
6.
Łoś, P., et al.. (1994). Interference of ϵ-amino-caproic acid with [N-succinimidyl S-acetylthioacetate derived] thiol-introduction into glu-plasminogen. Fibrinolysis and Proteolysis. 8. 138–141. 1 indexed citations
7.
Łoś, P., et al.. (1992). Development of a procedure for coupling the homing device glu-plasminogen to liposomes. Biochimica et Biophysica Acta (BBA) - General Subjects. 1117(3). 258–264. 24 indexed citations
8.
Leebeek, Frank W.G., et al.. (1990). Plasmin inhibitors in the prevention of systemic effects during thrombolytic therapy: Specific role of the plasminogen-binding form of α2-antiplasmin. Journal of the American College of Cardiology. 15(6). 1212–1220. 13 indexed citations
9.
Kardaun, Sylvia H., et al.. (1990). Increased urinary excretion of the histamine metabolite Nι-methylhistamine during acetylsalicylic acid provocation in chronic urticaria patients. Inflammation Research. 30(1-2). 254–257. 2 indexed citations
10.
Kluft, Cornelis, A.F.H. Jie, P. Łoś, E. de Wit, & Louis M. Havekes. (1989). Functional analogy between lipoprotein(a) and plasminogen in the binding to the kringle 4 binding protein, tetranectin. Biochemical and Biophysical Research Communications. 161(2). 427–433. 61 indexed citations
11.
Kluft, Cornelis, P. Łoś, & Inge Clemmensen. (1989). Calcium-dependent binding of tetranectin to fibrin. Thrombosis Research. 55(2). 233–238. 29 indexed citations
12.
Kluft, Cornelis, P. Łoś, Inge Clemmensen, et al.. (1989). Quantitation of Plasma Levels of Tetranectin - Effects of Oral Contraceptives, Pregnancy, Treatment with L-Asparaginase and Liver Cirrhosis. Thrombosis and Haemostasis. 62(2). 792–796. 11 indexed citations
13.
Kluft, Cornelis & P. Łoś. (1988). Modified Crossed Immunoelectrophoresis to Study with Whole Plasma the Reversible Complex Formation of Histidine-Rich Glycoprotein with Plasminogen. Thrombosis and Haemostasis. 60(3). 411–414. 9 indexed citations
14.
Kluft, Cornelis, et al.. (1986). The mutual relationship between the two molecular forms of the major fibrinolysis inhibitor alpha-2-antiplasmin in blood. Blood. 67(3). 616–622. 29 indexed citations
15.
Rijken, D.C., et al.. (1986). Specific fibrinolytic properties of different molecular forms of pro-urokinase from a monkey kidney cell culture. Thrombosis Research. 42(6). 761–768. 11 indexed citations
16.
Kluft, Cornelis, P. Łoś, A.F.H. Jie, et al.. (1986). The mutual relationship between the two molecular forms of the major fibrinolysis inhibitor alpha-2-antiplasmin in blood. Blood. 67(3). 616–622. 37 indexed citations
17.
Kluft, Cornelis, P. Łoś, & A.F.H. Jie. (1984). The molecular form of α2-antiplasmin with affinity for plasminogen is selectively bound to fibrin by factor XIII. Thrombosis Research. 33(4). 419–425. 17 indexed citations
18.
Kluft, Cornelis, et al.. (1983). THE MUTUAL RELATION BETWEEN THE 2 MOLECULAR-FORMS OF ALPHA-2-ANTIPLASMIN IN BLOOD. Data Archiving and Networked Services (DANS). 50(1). 170–170. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026